Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer

Not Applicable

Completed

Conditions: Prostate Cancer

First Posted Date: 2024-07-01

Last Posted Date: 2025-04-08

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 380

Registration Number: NCT06482658

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery

Not Applicable

Not yet recruiting

Conditions: Repetitive Transcranial Magnetic Stimulation
Cognitive Impairment
Postoperative Neurocognitive Disorder
Older Patients
Delayed Neurocognitive Recovery

First Posted Date: 2024-07-01

Last Posted Date: 2025-05-08

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 568

Registration Number: NCT06482749

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳
Peking University Shenzhen Hospital, Shenzhen, Guangzhou, China
🇨🇳
Xijing Hospital, Air Force Medical University, Xi'an, Shannxi, China

Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer

Not Applicable

Recruiting

Conditions: Prostate Cancer

First Posted Date: 2024-07-01

Last Posted Date: 2024-07-23

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 300

Registration Number: NCT06482645

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Blood Biomarkers for Screening of Alzheimer's Disease

Recruiting

Conditions: Alzheimer's Disease
Blood Biomarkers

First Posted Date: 2024-06-27

Last Posted Date: 2024-06-27

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 180

Registration Number: NCT06477484

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Neoadjuvant Radiotherapy for High-risk UTUC

Not yet recruiting

Conditions: Urothelial Carcinoma of the Renal Pelvis and Ureter

First Posted Date: 2024-06-25

Last Posted Date: 2024-06-25

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 40

Registration Number: NCT06472752

Locations: 🇨🇳
Departmeng of Urology, Peking University First Hospital, Beijing, China

Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients

Not Applicable

Not yet recruiting

Conditions: Intensive Care Units
Esketamine
Aged
Ventilators, Mechanical
Dexmedetomidine
Delirium

Interventions: Drug: Dexmedetomidine-Esketamine Combination
Drug: Dexmedetomidine

First Posted Date: 2024-06-21

Last Posted Date: 2024-10-08

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1508

Registration Number: NCT06468436

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳
Peking University International Hospital, Beijing, Beijing, China
🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Fractional Flow Reserve-guided Stenting Versus Medical Therapy in Atherosclerosis Renal Artery Stenosis

Not Applicable

Recruiting

Conditions: Secondary Hypertension Renal Arterial
Renal Artery Stenosis Atherosclerotic

Interventions: Drug: Dopamine
Diagnostic Test: Fractional Flow Reserve, Renal
Device: Renal artery stenting

First Posted Date: 2024-06-07

Last Posted Date: 2024-08-16

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 200

Registration Number: NCT06447740

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma

Recruiting

Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Cutaneous T Cell Lymphoma

First Posted Date: 2024-05-31

Last Posted Date: 2024-05-31

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 100

Registration Number: NCT06436677

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients

Phase 4

Not yet recruiting

Conditions: Type 2 Diabetes

Interventions: Drug: Combination therapy
Drug: Sequential treatment group

First Posted Date: 2024-05-16

Last Posted Date: 2024-05-16

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 160

Registration Number: NCT06417489

Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting

Phase 4

Recruiting

Conditions: Postoperative Nausea and Vomiting

Interventions: Drug: Oliceridine
Drug: Morphine

First Posted Date: 2024-05-13

Last Posted Date: 2024-10-08

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 252

Registration Number: NCT06411665

Locations: 🇨🇳
Dong-Xin Wang, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy